Monoclonal antibody production by EBV transformation of B cells
Details for Australian Patent Application No. 2004215125 (hide)
International Classifications
Event Publications
2 August 2007 Section 223 Application Received
INSTITUTE FOR RESEARCH IN BIOMEDICINE An application to extend the time from 26 Sep 2005 to 26 May 2007 in which to enter the national phase has been filed . Address for service in Australia - FB Rice & Co Level 23 44 Market Street Sydney NSW 2000
20 September 2007 Section 223 Application Allowed
INSTITUTE FOR RESEARCH IN BIOMEDICINE The time in which to enter the national phase has been extended to 26 May 2007. Address for service in Australia - FB Rice & Co Level 23 44 Market Street Sydney NSW 2000
27 September 2007 PCT application entered the National Phase
PCT publication WO2004/076677 Priority application(s): WO2004/076677
6 January 2011 Application Accepted
Published as AU-B-2004215125
12 May 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004215127-Fabric with high fire-resistant properties
2004215120-Human antibodies specific for interleukin 15 (IL-15)
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser